B. Riley Securities Maintains Neutral on Transphorm, Lowers Price Target to $3.5
Portfolio Pulse from Benzinga Newsdesk
B. Riley Securities analyst Craig Ellis has maintained a Neutral rating on Transphorm (NASDAQ:TGAN) and lowered the price target from $4.5 to $3.5.
August 15, 2023 | 3:16 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
B. Riley Securities has maintained a Neutral rating on Transphorm and lowered the price target from $4.5 to $3.5.
The lowering of the price target by B. Riley Securities indicates a less optimistic outlook for Transphorm, which could negatively impact investor sentiment and potentially lead to a decrease in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100